Publication:
5-(4 Synthesis, Characterization, DFT Study and Antimicrobial Activity

dc.authorscopusid8361744500
dc.authorscopusid26644545800
dc.authorscopusid8354984100
dc.authorscopusid6506730197
dc.contributor.authorUstabaş, R.
dc.contributor.authorSüleymanoǧlu, N.
dc.contributor.authorÜnver, Y.
dc.contributor.authorDirekel, Ş.
dc.date.accessioned2020-06-20T22:08:25Z
dc.date.available2020-06-20T22:08:25Z
dc.date.issued2020
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ustabaş] Reşat, Technical Sciences Vocational School, Gazi Üniversitesi, Ankara, Ankara, Turkey; [Süleymanoǧlu] Nevin, Department of Mathematics and Science Education, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ünver] Yasemin, Department of Chemistry, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Direkel] Şahin, Department of Medical Microbiology, Giresun Üniversitesi, Giresun, Giresun, Turkeyen_US
dc.description.abstractSince molecules containing 1,3,4-oxadiazoles and 1,2,4-triazole heterocyclic rings in their structures have important biological activities; 5-(4-Bromobenzyl)-4-(4-(5-phenyl-1,3,4-oxadiazole-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazole-3-one (II) was synthesized, the synthesized compound was characterized by using NMR and IR spectroscopic methods. HOMO and LUMO energies, geometrical structure parameters, IR parameters and NMR chemical shift values were calculated by using DFT method. IR and NMR experimental values were compared with DFT results. Due to the differences between experimental IR and NMR spectral values and theoretical ones, N–H⋯O type intermolecular strong hydrogen bond was recommended. Antimicrobial activities of the synthesized compound II was determined against fifteen different bacteria and the Leishmania major species by microdilution broth assay with Alamar Blue Dye. Compound II was found to be low effective on three different bacterial species (Minimum Inhibitory Concentration (MIC):5000 μg/ml) and had the high antileishmanial activity (MIC: 1250 μg/mL). In order to use the synthesized compound as a drug candidate, control studies should be performed in experimental animal models in vivo. © 2020en_US
dc.identifier.doi10.1016/j.molstruc.2020.128217
dc.identifier.issn0022-2860
dc.identifier.scopus2-s2.0-85083076189
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2020.128217
dc.identifier.volume1214en_US
dc.identifier.wosWOS:000535457100008
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofJournal of Molecular Structureen_US
dc.relation.journalJournal of Molecular Structureen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntimicrobial Activityen_US
dc.subjectDFT Calculationsen_US
dc.subjectFTIR and NMRen_US
dc.subjectLeishmania majoren_US
dc.subjectOxadiazoleen_US
dc.subjectTriazoleen_US
dc.title5-(4 Synthesis, Characterization, DFT Study and Antimicrobial Activityen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files